Cover Image
市場調查報告書

消費者醫療保健的全球市場:2016∼2020年

Global Consumer Healthcare Market 2016-2020

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 353190
出版日期 內容資訊 英文 105 Pages
訂單完成後即時交付
價格
Back to Top
消費者醫療保健的全球市場:2016∼2020年 Global Consumer Healthcare Market 2016-2020
出版日期: 2016年02月24日 內容資訊: 英文 105 Pages
簡介

消費者醫療保健產品的特長廣泛,由於消費者的需求和文明病的罹患率上升,使市場擴大。過敏照護,減肥補給品、止痛、口腔衛生等變成受到歡迎的類別。全球消費者醫療保健市場,預計2016∼2020年以年複合成長率9.26%擴大。

本報告提供全球消費者醫療保健市場現狀與今後的成長預測,各地區趨勢,以及市場趨勢與課題,主要供應商簡介等彙整資料。

第1章 摘要整理

第2章 本報告的範圍

第3章 市場調查方法

第4章 簡介

  • 市場焦點

第5章 概要:消費者醫療保健市場

  • 成藥
  • 減肥補給品
  • 主要的購買標準
  • 打入市場策略的影響因素

第6章 市場情況

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各產品市場區隔

  • 成藥
  • 減肥補給品

第8章 各地區市場區隔

  • 南北美洲
  • 亞太地區
  • 歐洲、中東、非洲

第9章 主要國家

  • 美國
  • 中國
  • 日本

第10章 推動市場的要素

  • 文明病的認識
  • 自我治療的增加
  • 高齡化
  • 可支配所得的上升
  • 由處方藥轉移到OTC藥的增加

第11章 促進要素的影響

第12章 市場課題

  • 激烈競爭
  • 妥當文獻的不足
  • 副作用
  • 仿冒品
  • 嚴厲的法律規章和指南

第13章 促進要素及課題的影響

第14章 市場趨勢

第15章 供應商環境

  • 競爭模式
  • 市場佔有率:2015年

第16章 主要供應商分析

  • Johnson & Johnson
  • Bayer HealthCare
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Boehringer Ingelheim
  • 其他值得注意的供應商

第17章 附錄

第18章 關於Technavio

圖表

目錄
Product Code: IRTNTR8817

About Consumer Healthcare

The characteristics of consumer health products vary widely, with the two most important elements being the consumer needs they address and the strength of the claims made. The market for consumer-focused healthcare products is increasingly occupying the space between consumer needs and growing prevalence of lifestyle diseases. As consumer health companies develop a combination of consumer goods and pharmaceuticals, they have the ability to engage consumers by proving the clinical effectiveness of their products. These companies recognize unmet consumer needs and develop inventive ways to establish their presence in the marketplace.

Allergy care, dietary supplements, feminine care, pain relief, respiratory, and oral health are among the popular consumer health product categories. Some well-known products in the market are Voltaren and Panadol by GlaxoSmithKline; Lactacyd and Dermacyd by Sanofi; and Nexium, Advil, and Caltrate by Pfizer.

Technavio's analysts forecast the global consumer healthcare market to grow at a CAGR of 9.26% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global consumer healthcare market for the period 2016-2020. To calculate the market size, the report considers revenue generated from the sales of OTC pharmaceuticals and dietary supplements.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Consumer Healthcare Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Bayer HealthCare
  • Boehringer Ingelheim
  • GlaxoSmithKline
  • Johnson & Johnson
  • Pfizer
  • Sanofi

Other Prominent Vendors

  • Abbott Laboratories
  • American Health
  • Amway
  • Arena Pharmaceuticals
  • BASF
  • BioGaia
  • Bukwang Pharmaceutica
  • Chr. Hansen
  • Danone
  • DSM
  • Eisai
  • EMS
  • Euradite Consumer Health and Life Care
  • Friggs
  • Genomma Lab Internacional
  • Glanbia
  • Herbalife
  • The Himalaya Drug Company
  • Kellogg
  • McNeil Consumer Healthcare
  • Mead Johnson Nutrition
  • Merck
  • Mitsubishi Tanabe Pharma
  • Nestle
  • Novartis
  • Nutrition & Sante
  • Omega Pharma
  • Procter & Gamble
  • Reckitt Benckiser
  • SAVA Global
  • Sigma Pharmaceuticals
  • Sun Pharma
  • Taisho Pharmaceuticals
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
  • Unifarma Global Consumer Healthcare
  • Vida Laboratories
  • Yakult Danone India

Market driver

  • Awareness about lifestyle diseases
  • For a full, detailed list, view our report

Market challenge

  • Intense competition
  • For a full, detailed list, view our report

Market trend

  • Accelerated use of online resources
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Overview: Consumer healthcare market

  • OTC pharmaceuticals
  • Dietary supplements
  • Key buying criteria
  • Factors influencing go-to-market strategy

PART 06: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 07: Market segmentation by consumer healthcare products

  • OTC pharmaceuticals
  • Dietary supplements

PART 08: Geographical segmentation

  • Global consumer healthcare market by geographical segmentation 2016-2020
  • Consumer healthcare market in Americas
  • Consumer healthcare market in APAC
  • Consumer healthcare market in EMEA

PART 09: Key leading countries

  • US
  • China
  • Japan

PART 10: Market drivers

  • Awareness about lifestyle diseases
  • Increase in self-medication
  • Growing older population
  • Rise in disposable income
  • Increase in switch from prescription to OTC products

PART 11: Impact of drivers

PART 12: Market challenges

  • Intense competition
  • Lack of valid literature
  • Adverse effects
  • Counterfeit pharmaceuticals
  • Stringent regulations and guidelines

PART 13: Impact of drivers and challenges

PART 14: Market trends

  • Accelerated use of online resources
  • New product launches
  • Promotions and marketing initiatives
  • Strategic alliances

PART 15: Vendor landscape

  • Competitive scenario
  • Market share 2015

PART 16: Key vendor analysis

  • Johnson & Johnson
  • Bayer HealthCare
  • GlaxoSmithKline
  • Sanofi
  • Pfizer
  • Boehringer Ingelheim
  • Other prominent vendors

PART 17: Appendix

  • List of abbreviations

PART 18: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Types of consumer healthcare products
  • Exhibit 03: Key regulatory bodies that approve OTC products
  • Exhibit 04: FDA OTC drug approval process
  • Exhibit 05: Mechanisms to amend OTC drug monograph
  • Exhibit 06: Comparison of OTC NDA versus OTC monograph process
  • Exhibit 07: Strategies to establish OTC pharmaceuticals in emerging markets
  • Exhibit 08: Recommendation of dietary supplements by health professionals
  • Exhibit 09: Key buying criteria in global consumer healthcare market
  • Exhibit 10: Factors that influence the go-to-market strategy in global consumer healthcare market
  • Exhibit 11: Global consumer healthcare market 2015-2020 ($ billions)
  • Exhibit 12: Five forces analysis
  • Exhibit 13: Segmentation of global consumer healthcare market by products
  • Exhibit 14: Global OTC pharmaceuticals market 2015-2020 ($ billions)
  • Exhibit 15: Global OTC pharmaceuticals market by geography 2015
  • Exhibit 16: Segmentation of global OTC pharmaceuticals by therapeutic class
  • Exhibit 17: Global OTC pharmaceuticals market segmentation by therapeutic class 2015
  • Exhibit 18: Drivers and challenges of global OTC pharmaceuticals market
  • Exhibit 19: Global dietary supplements market 2015-2020 ($ billions)
  • Exhibit 20: Global dietary supplements market by geography 2015
  • Exhibit 21: Segmentation of global dietary supplements market by product type
  • Exhibit 22: Global dietary supplements market by product type 2015
  • Exhibit 23: Drivers and challenges of global dietary supplements market
  • Exhibit 24: Segmentation of global consumer healthcare market by geography 2015
  • Exhibit 25: Global consumer healthcare market revenue by geography 2015-2020 ($ billions)
  • Exhibit 26: Global consumer healthcare market revenue by geography 2015-2020
  • Exhibit 27: Consumer healthcare market in Americas 2015-2020 ($ billions)
  • Exhibit 28: Consumer healthcare market in APAC 2015-2020 ($ billions)
  • Exhibit 29: Consumer healthcare market in EMEA 2015-2020 ($ billions)
  • Exhibit 30: Key leading countries in global consumer healthcare market
  • Exhibit 31: Drivers and challenges
  • Exhibit 32: Drivers and challenges
  • Exhibit 33: Drivers and challenges
  • Exhibit 34: Impact of drivers
  • Exhibit 35: Impact of drivers and challenges
  • Exhibit 36: Global internet penetration rate 2015
  • Exhibit 37: Johnson & Johnson: Business segmentation by revenue 2014
  • Exhibit 38: Johnson & Johnson: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
  • Exhibit 39: Johnson & Johnson: Consumer healthcare product categories by revenue 2014
  • Exhibit 40: Johnson & Johnson: YOY growth rate and revenue of OTC products 2012-2014 ($ billions)
  • Exhibit 41: Johnson & Johnson: YoY growth rate and revenue of skin care products 2012-2014 ($ billions)
  • Exhibit 42: Johnson & Johnson: YoY growth rate and revenue of baby care products 2012-2014 ($ billions)
  • Exhibit 43: Johnson & Johnson: YoY growth rate and revenue of oral care category 2012-2014 ($ billions)
  • Exhibit 44: Johnson & Johnson: YoY growth rate and revenue of wound care/other products 2012-2014 ($ billions)
  • Exhibit 45: Johnson & Johnson: YoY growth rate and revenue of women's health products 2012-2014 ($ billions)
  • Exhibit 46: Johnson & Johnson: Geographical segmentation by consumer healthcare revenue 2014
  • Exhibit 47: Johnson & Johnson: SWOT analysis
  • Exhibit 48: Bayer HealthCare: Business segmentation by revenue 2014
  • Exhibit 49: Bayer HealthCare: Consumer health segmentation by revenue 2014
  • Exhibit 50: Bayer HealthCare: Geographic segmentation of consumer healthcare segment 2014
  • Exhibit 51: Bayer HealthCare: YoY growth rate and revenue of Contour 2012-2014 ($ millions)
  • Exhibit 52: Bayer HealthCare: YoY growth rate and revenue of Advantage 2012-2014 ($ millions)
  • Exhibit 53: Bayer HealthCare: YoY growth rate and revenue of Aspirin 2012-2014 ($ millions)
  • Exhibit 54: Bayer HealthCare: YoY growth rate and revenue of Aleve 2012-2014 ($ millions)
  • Exhibit 55: Bayer HealthCare: YoY growth rate and revenue of Bepanthen/Bepanthol 2012-2014 ($ millions)
  • Exhibit 56: Bayer Healthcare: SWOT analysis
  • Exhibit 57: GlaxoSmithKline: Business segmentation by revenue 2014
  • Exhibit 58: GlaxoSmithKline: YoY growth rate and revenue of consumer healthcare segment 2012-2014 ($ billions)
  • Exhibit 59: GlaxoSmithKline: Segmentation of consumer healthcare categories by revenue 2012-2014
  • Exhibit 60: GlaxoSmithKline: YoY growth rate and revenue of oral health products 2012-2014 ($ billions)
  • Exhibit 61: GlaxoSmithKline: YoY growth rate and revenue of wellness products 2012-2014 ($ billions)
  • Exhibit 62: GlaxoSmithKline: YoY growth rate and revenue of nutrition products 2012-2014 ($ millions)
  • Exhibit 63: GlaxoSmithKline: YoY growth rate and revenue of skin health category 2012-2014 ($ millions)
  • Exhibit 64: GlaxoSmithKline: Geographical segmentation by consumer health revenue 2014
  • Exhibit 65: GlaxoSmithKline: SWOT analysis
  • Exhibit 66: Sanofi: Business segmentation by revenue 2014
  • Exhibit 67: Sanofi: Pharmaceutical segment by revenue 2014
  • Exhibit 68: Sanofi: Geographical segmentation by consumer healthcare revenue 2014
  • Exhibit 69: Sanofi: YoY growth rate and revenue of Allegra 2012-2014 ($ millions)
  • Exhibit 70: Sanofi: YoY growth rate and revenue of Doliprane 2012-2014 ($ millions)
  • Exhibit 71: Sanofi: YoY growth rate and revenue of Essentiale 2012-2014 ($ millions)
  • Exhibit 72: Sanofi: YoY growth rate and revenue of Enterogermina 2012-2014 ($ millions)
  • Exhibit 73: Sanofi: YoY revenue comparison of Nasacort 2013 and 2014 ($ millions)
  • Exhibit 74: Sanofi: SWOT Analysis
  • Exhibit 75: Pfizer: Business segmentation by revenue 2014
  • Exhibit 76: Pfizer: Global vaccines, oncology, and consumer healthcare segment by revenue 2014
  • Exhibit 77: Pfizer: YoY growth rate and revenue of consumer healthcare category 2012-2014 ($ billions)
  • Exhibit 78: Pfizer: SWOT analysis
  • Exhibit 79: Boehringer Ingelheim: Business segmentation by revenue 2014
  • Exhibit 80: Boehringer Ingelheim: YoY revenue and growth rate of Buscopan 2012-2014 ($ millions)
  • Exhibit 81: Boehringer Ingelheim: YoY revenue and growth rate of Dulcolax 2012-2014 ($ millions)
  • Exhibit 82: Boehringer Ingelheim: YoY revenue and growth rate of Mucosolvan 2012-2014 ($ millions)
  • Exhibit 83: Boehringer Ingelheim: YoY revenue and growth rate of Pharmaton 2012-2014 ($ millions)
  • Exhibit 84: Boehringer Ingelheim: SWOT analysis
Back to Top